Keyphrases
Patients with Heart Failure
100%
Sacubitril-valsartan
100%
End-stage Kidney Disease
100%
Heart Failure with Preserved Ejection Fraction (HFpEF)
75%
Left Ventricular Function
25%
Conventional Treatment
25%
Heart Failure
12%
Chronic Disease
12%
Heart Failure Hospitalization
12%
Left Ventricular Ejection Fraction
12%
Echocardiographic Parameters
12%
High Prevalence
12%
Treatment Group
12%
Echocardiogram
12%
Heart Function
12%
Serum Potassium
12%
Left Ventricular Systolic Function
12%
Treatment Parameters
12%
Heart Failure Management
12%
Global Mortality
12%
Hospitalization Rate
12%
PARADIGM-HF
12%
Heart Failure Trials
12%
Angiotensin Receptor-neprilysin Inhibitor
12%
Left Ventricular End-diastolic Volume (LVEDV)
12%
End-systole
12%
Advanced Kidney Disease
12%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
End Stage Renal Disease
100%
Valsartan/Sacubitril
100%
Heart Failure with Reduced Ejection Fraction
75%
Prevalence
12%
Isotopes of Potassium
12%
Kidney Disease
12%
Chronic Disease
12%
Enkephalinase Inhibitor
12%
Treatment Group
12%